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Abstract
Optimal timing of apheresis initiation is important for maximizing the hematopoietic stem cell
(HSC) yield. This study aimed to identify useful parameters from automatic hematology ana-
lyzers for predicting the peripheral blood CD34+ cell count after mobilization. We prospec-
tively enrolled 53 healthy donors and 72 patients, and evaluated 43 cell morphology
parameters from Unicel DxH800 (Beckman Coulter, USA) and Advia 2120i (Siemens
Healthcare Diagnostics, USA). The correlation of each parameter with the CD34+ cell count
in pre-apheresis blood samples was analyzed. The delta neutrophil index (DNI) from Advia
2120i, standard deviation of volume of neutrophils and monocytes (SD-V-NE and SD-V-
MO), standard deviation of conductivity of neutrophils and monocytes (SD-C-NE and SD-C-
MO), mean conductivity of neutrophils and monocytes (MN-C-NE and MN-C-MO), and stan-
dard deviation of axial light loss of neutrophils and monocytes (SD-AL2-NE and SD-AL2-
MO) from DxH800 showed significant correlations with the CD34+ cell count. SD-V-NE, SD-
C-NE, and SD-C-MO showed good or fair area under the curve values for the prediction of
the CD34+ cell count. SD-V-NE, SD-C-NE, and SD-C-MO from DxH800 will provide rapid,
useful information for the initiation of apheresis after mobilization.
Introduction
Hematopoietic stem cell (HSC) transplantation is widely used in the curative treatment of a
number of malignancies and immunologic diseases [1]. For successful transplantation, an ade-
quate amount of HSC infusion is necessary [2]. Poor mobilizers with failure to achieve the
minimal amount of HSCs for engraftment show prolonged engraftment time and worse prog-
nosis [3]. The timing of the initiation of the apheresis schedule is important for maximizing
the HSC yield in an apheresis product [4]. The most accurate and recommended method to
predict the HSC yield is measuring the CD34+ cell count in peripheral blood (PB); however,
this requires an additional 1–2 hours of analysis time, a flow-cytometer and reagents, and
PLOS ONE | https://doi.org/10.1371/journal.pone.0174286 March 20, 2017 1 / 7
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Shin S, Cho SR, Kim S, Choi JR, Lee K-A
(2017) Identification of cell morphology
parameters from automatic hematology analyzers
to predict the peripheral blood CD34-positive cell
count after mobilization. PLoS ONE 12(3):
e0174286. https://doi.org/10.1371/journal.
pone.0174286
Editor: Francesco Bertolini, European Institute of
Oncology, ITALY
Received: January 8, 2017
Accepted: March 6, 2017
Published: March 20, 2017
Copyright: © 2017 Shin et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This study was supported by a grant
from the Korean Health Technology R&D Project,
Ministry of Health & Welfare, Republic of Korea
(A120030, http://www.htdream.kr/, KAL). The
funder had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
experienced technicians [5]. Therefore, surrogate markers obtained by an easy and inexpensive
method can aid in daily HSC monitoring and allow fast medical decision-making for apheresis
initiation.
Automatic hematologic analyzers differentiate leukocyte subpopulations using the princi-
ples of electrical impedance, radiofrequency conductivity, light scattering, and/or cytochemis-
try [6]. In the process, variable cell morphology parameters, derived from multiple channels
and reflecting the cell size, cytoplasmic granularity, and nuclear lobularity, are obtained [6].
Recently, hematopoietic progenitor cells (HPCs) measured by the Sysmex hematology analyzer
(Sysmex, Kobe, Japan) have been used as an estimate of immature cells in PB and as a marker
for initiation of apheresis [7,8]. The HPC count by the Sysmex analyzer is determined by the
combination of cell size and density, along with a resistance characteristic of immature cells to
a lysis reagent [9]. However, HPCs can only be utilized in laboratories using the Sysmex
analyzer.
Advia 2120i (Siemens Healthcare Diagnostics, Deerfield, IL, USA) differentiates leukocyte
subfractions using two channels: enzyme activity determination in the myeloperoxidase chan-
nel and nuclear complexity determination in the nuclear lobularity channel. The delta neutro-
phil index (DNI) is calculated by subtraction of the percentage of polymorphonuclear cells
determined in the nuclear lobularity channel from the sum of the percentages of neutrophils
and eosinophils, determined in the myeloperoxidase channel [10]. Therefore, the DNI reflects
the immature leukocyte subfraction, which has myeloperoxidase activity and lacks nuclear
lobularity [11].
Unicel DxH800 (Beckman Coulter, Miami, FL, USA) uses electrical impedance, radiofre-
quency conductivity, and light scattering to count and differentiate leukocyte subpopulations.
Through the measurement data referred to above, 42 cell morphology parameters, which
reflect the cell size and internal physical and chemical compositions, are acquired [6]. An
increase of the immature leukocyte subfraction in a sample might lead to an increase in varia-
tion of the volume and conductivity of each leukocyte subpopulation.
These parameters from the Siemens and Coulter hematology analyzers have been investi-
gated for their diagnostic and prognostic impact on diseases or states characterized by changes
in leukocyte morphology, such as infection, sepsis, hematologic disorders, and granulocyte-
colony stimulating factor (G-CSF) administration [11–15]. In this study, we aimed to investi-
gate whether cell morphology parameters from the Siemens and Coulter analyzers can also be
used for the prediction of the CD34+ cell count after mobilization.
Materials and methods
Patients and stem cell mobilization
From July 2013 to January 2016, 53 healthy donors for allogeneic HSC transplantation and 72
patients with hematologic malignancy undergoing autologous transplantation were prospec-
tively recruited for this study. This study was approved by the institutional review board of the
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Written informed
consent was obtained from all participants in accordance with the Declaration of Helsinki. For
all healthy donors and 15/72 patients, the standard dose of G-CSF (10 μg/kg/day) was used for
mobilization and collection was initiated on the fifth day of G-CSF initiation. For the remain-
ing 57 patients, chemotherapy followed by G-CSF was used for mobilization, and collection
was started when the PB white blood cell count increased to 3,000/μL after reaching the nadir.
A whole blood sample was taken from all participants immediately prior to the first apheresis.
Aliquots of the sample were tested for the CD34+ cell count using flow cytometry, and for the
complete blood count using two automated hematology analyzers in parallel: the Unicel
CBC parameter for prediction of stem cell
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DxH800 (Beckman Coulter) and Advia 2120i (Siemens Healthcare Diagnostics). In some of
the patients (101/125 patients, 80.8%), CD34+ cell count in apheresis product was acquired by
reviewing medical records, and two parameters of HSC yield (CD34+ cells/μL in a product
and total CD34+ cells/kg donor body weight) were compared with PB CD34+ cell count.
Complete blood count
Using DxH800, 42 parameters related to the morphology of leukocytes were obtained from
calculations of the mean and standard deviation cell volume, conductivity, and five-angle light
scattering measurements [13,14]. Using Advia 2120i, the DNI percentage was obtained as the
following formula: DNI (%) = (the leukocyte subfraction assayed in the myeloperoxidase chan-
nel by cytochemical reaction)–(the leukocyte subfraction counted in the nuclear lobularity
channel by the reflected light beam) [10].
CD34-positive cell count
The CD34+ cells were enumerated using Stem-Kit reagent (Beckman coulter) according to the
manufacturer’s instructions. After vortexing of EDTA specimen, 100 μL aliquot was incubated
for 20 min with 20 μL mixture of CD45-FITC monoclonal antibody and CD34-PE monoclonal
antibody in the first tube, and with 20 μL mixture of CD45-FITC and IsoClonic control-PE
reagent in the second tube. In each tube, 20 μL of viability dye 7-AAD was added to distinguish
between viable and nonviable cells. In order to lyse erythrocytes, 2 mL of NH4Cl lysing buffer
was added and incubated for 10 min. For absolute count of CD34+ cells, 100 μL of stem cell
fluorosphere with known concentration was added and incubated for 5 min. After gentle mix-
ing, the product was analyzed on FC500 flow cytometer (Beckman coulter) following manu-
facturers’ recommendations, based on a gating protocol developed by the International
Society of Hematotherapy and Graft Engineering (ISHAGE) [16]. A total of 75,000 CD45
+ events were acquired for each sample. Among viable CD45+ and CD34+ events, cells with
dim CD45 expression and low sideward light scatter were selected, and events falling outside
the cluster of cells with low-to-intermediate forward light scatter were excluded. Absolute
CD34+ cell count was calculated using the ratio of fluorosphere to CD34+ cell numbers.
Statistical analysis
Correlations between continuous variables were analyzed using Pearson’s correlation test after
natural-log transformation of variables with skewed distribution. The diagnostic accuracy
thresholds of the area under the receiver operating characteristic curve (AUC of ROC) were as
follows: 1–0.9, excellent; 0.9–0.8, good; 0.8–0.7, fair; 0.7–0.6, poor; and 0.6–0.5, fail [17]. All P-
values were two-sided, and values< 0.05 were considered significant. Statistical analysis was
performed using SPSS Statistics version 23.0.0 (IBM Corp., Armonk, NY, USA).
Results
This study included a total of 125 subjects, including 53 healthy donors and 72 patients with
hematologic malignancy. On the first apheresis day, the median number of CD34+ cells/μL in
the PB was 46 (interquartile range, 26–84). The PB CD34+ cell count before apheresis was
highly correlated with CD34+ cells/μL in a product (r = 0.933, P< 0.001) and total CD34
+ cells/kg donor body weight (r = 0.936, P< 0.001) (Fig 1).
Among a total of 43 cell morphology parameters, nine parameters: the DNI from Advia
2120i, the standard deviation of volume of neutrophils (SD-V-NE), standard deviation of vol-
ume of monocytes (SD-V-MO), standard deviation of conductivity of neutrophils (SD-C-NE),
CBC parameter for prediction of stem cell
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standard deviation of conductivity of monocytes (SD-C-MO), mean conductivity of neutro-
phils (MN-C-NE), mean conductivity of monocytes (MN-C-MO), standard deviation of axial
light loss of neutrophils (SD-AL2-NE), and standard deviation of axial light loss of monocytes
(SD-AL2-MO) from DxH800 showed significant correlations with the PB CD34+ cell count
after mobilization (Table 1). Next, we calculated the AUCs of the six cell morphology parame-
ters for prediction of each target point of the PB CD34+ cell count. The ROC curve analysis
revealed that SD-V-NE, SD-C-NE, and SD-C-MO showed good or fair AUCs in the prediction
of several different CD34+ cell count targets.
Fig 1. Scatter plots and Pearson’s correlation analyses between (A) PB CD34+ cells/μL and CD34+ cells/μL in a product, and (B) PB CD34
+ cells/μL and total CD34+ cells/kg donor body weight (×106). PB, peripheral blood.
https://doi.org/10.1371/journal.pone.0174286.g001
Table 1. Receiver operating characteristics analysis using cell morphology parameters for prediction of the CD34+ cell count.
AUC for target CD34+ cells/μL in PB
Parametersa rb P-value < 15, 15 (n=20, 105) < 20, 20 (n=25, 100) < 25, 25 (n=31, 94) < 30, 30 (n=39, 86)
DNI 0.416 < 0.001 0.598 0.587 0.617 0.633
SD-V-NE 0.313 < 0.001 0.697 0.716 0.728 0.695
SD-V-MO 0.289 0.001 0.691 0.624 0.631 0.573
SD-C-NE 0.285 0.001 0.845 0.778 0.769 0.704
MN-C-NE -0.275 0.002 0.588 0.563 0.553 0.540
SD-C-MO 0.256 0.004 0.761 0.699 0.705 0.648
SD-AL2-MO 0.246 0.006 0.606 0.574 0.603 0.573
SD-AL2-NE 0.226 0.01 0.535 0.507 0.530 0.506
MN-C-MO -0.197 0.03 0.625 0.606 0.567 0.515
AUC, area under the receiver operating characteristics curve; PB, peripheral blood; DNI, delta neutrophil index; SD, standard deviation; V, volume; NE,
neutrophil; MO, monocyte; C, conductivity; MN, mean; AL2, axial light loss.
a The remaining 34 parameters with a P-value of Pearson’s correlation test 0.05 were omitted.
b Pearson’s correlation coefficient between parameters from hematologic analyzers and peripheral blood CD34+ cell count.
https://doi.org/10.1371/journal.pone.0174286.t001
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Discussion
In this study, we identified cell morphology parameters for predicting the PB CD34+ cell
count after mobilization. These parameters can be acquired during a complete blood count
test, and there is no need for additional samples, reagents, and analysis time. Rapid prediction
of mobilization failure enables poor mobilizer to use alternative strategies, such as immediate
salvage plerixafor [18].
In our dataset, PB CD34+ cell count before apheresis was highly correlated with HSC yields.
Therefore, we used PB CD34+ cell count as a reference value for deciding apheresis initiation.
DNI, SD-V-NE, SD-V-MO, SD-C-NE, SD-C-MO, MN-C-NE, MN-C-MO, SD-AL2-NE,
and SD-AL2-MO showed positive or negative correlations with the PB CD34+ cell count in
the present study. Lee et al reported that SD-V-NE, SD-V-MO, SD-C-NE, SD-C-MO,
MN-C-NE, MN-C-MO, SD-AL2-NE, and SD-AL2-MO were significantly increased in a
G-CSF administered group, as compared with in the control group [13]. Golubeva et al
reported that MN-V-NE and SD-V-NE correlated with the CD34+ cell count [5]; however,
only SD-V-NE significantly correlated with the CD34+ cell count in our study. These markers
can be regarded as reflecting a left shift of leukocytes, rather than a direct measurement of
stem cells in a sample. On the other hand, the Sysmex hematology analyzer uses a special lysis
reagent for differentiation of immature cells [9]. Therefore, it is possible that HPCs reflect the
immature cell population more specifically than parameters from the Siemens and Coulter
analyzers. Additional studies are needed to validate these parameters by comparison with
HPCs from the Sysmex analyzer in parallel.
Here, we provided evidence that clinical laboratories using hematology analyzers from
manufactures other than Sysmex can also use cell morphology parameters to predict the mobi-
lization outcome in clinical practice. In conclusion, SD-V-NE, SD-C-NE, and SD-C-MO can
be used as useful indicators for the prediction of optimal timing of HSC collection after
mobilization.
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